Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Motivational Interviewing for Adherence to Anti-Hypertensive Medications: A Randomized Controlled Trial

FY 2011-12

Summary
High blood pressure is the number one risk factor for premature death worldwide. Although blood pressure control may reduce premature cardiovascular mortality, many hypertensives do not achieve blood pressure within the normotensive range. A key barrier to hypertension management is medication adherence. Interventions that enhance motivation appear promising for improving adherence, but more randomized controlled research is needed to demonstrate efficacy. The present study aims to assess the efficacy of motivational interviewing (MINT) relative to a control condition among 60 non-adherent patients with uncontrolled hypertension using a randomized controlled trial. The control group will receive four education sessions regarding blood pressure etiology and pathophysiology (baseline, 3-, 6-, and 9-months). The intervention group will receive four sessions of MINT at the same intervals. The primary outcome is adherence to prescribed antihypertensive medication assessed with objective electronic monitoring (eCAPS) at one year follow-up. Patients in both groups will be assessed at baseline and after the 9-month session. It is expected that patients in MINT will demonstrate a greater rate of post-program medication adherence than controls. We will assess the effects of MINT on adherence using the analysis of covariance model with treatment group as the between-subjects factor and age, sex, depressed mood, change in medication, length of time taking antihypertensive medication, and baseline adherence as covariates. The present study will be the first randomized controlled trial of MINT with an active control condition and electronic monitoring of outcomes targeting adherence in hypertension. Given the effectiveness of anti-hypertensive medications, any research that helps improve medication adherence in this population will be instrumental to reducing cardiovascular morbidity and mortality.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
254053
Name
Rouleau Codie R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Motivational Interviewing for Adherence to Anti-Hypertensive Medications: A Randomized Controlled Trial
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adherence; Behavioral Medicine; Behaviour Change; Blood Pressure; Ecaps; Health Psychology; Hypertension; Motivational Interviewing; Randomized Controlled Trial
Abstract
High blood pressure is the number one risk factor for premature death worldwide. Although blood pressure control may reduce premature cardiovascular mortality, many hypertensives do not achieve blood pressure within the normotensive range. A key barrier to hypertension management is medication adherence. Interventions that enhance motivation appear promising for improving adherence, but more randomized controlled research is needed to demonstrate efficacy. The present study aims to assess the efficacy of motivational interviewing (MINT) relative to a control condition among 60 non-adherent patients with uncontrolled hypertension using a randomized controlled trial. The control group will receive four education sessions regarding blood pressure etiology and pathophysiology (baseline, 3-, 6-, and 9-months). The intervention group will receive four sessions of MINT at the same intervals. The primary outcome is adherence to prescribed antihypertensive medication assessed with objective electronic monitoring (eCAPS) at one year follow-up. Patients in both groups will be assessed at baseline and after the 9-month session. It is expected that patients in MINT will demonstrate a greater rate of post-program medication adherence than controls. We will assess the effects of MINT on adherence using the analysis of covariance model with treatment group as the between-subjects factor and age, sex, depressed mood, change in medication, length of time taking antihypertensive medication, and baseline adherence as covariates. The present study will be the first randomized controlled trial of MINT with an active control condition and electronic monitoring of outcomes targeting adherence in hypertension. Given the effectiveness of anti-hypertensive medications, any research that helps improve medication adherence in this population will be instrumental to reducing cardiovascular morbidity and mortality.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rouleau, Codie R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~